The University of Chicago Header Logo

Connection

Benjamin Derman to Bortezomib

Back to Details
This is a "connection" page, showing publications Benjamin Derman has written about Bortezomib.
Benjamin Derman
Connection Strength
0.205
Bortezomib
  1. Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 11; 22(11):e1000-e1008.
    View in: PubMed
    Score: 0.205
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.